By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Agenus (Formerly known as Antigenics Inc. - New York) 

Corporate Headquarters
3 Forbes Road
Lexington  Massachusetts  02421-7305  U.S.A.
Phone: 781-674-4400 Fax: 781-674-4200




Company News
Agenus (AGEN) Reports Second Quarter 2017 Financial Results And Provides Corporate Update 8/3/2017 12:45:59 PM
Agenus (AGEN) To Report Second Quarter 2017 Financial Results On August 3, 2017; Conference Call To Follow 7/27/2017 9:54:27 AM
Agenus (AGEN) To Report First Quarter 2017 Financial Results On May 4, 2017; Conference Call To Follow 4/27/2017 11:43:34 AM
Agenus (AGEN) Release: Company Announces Collaboration With The NCI To Evaluate The Combination Of Pembrolizumab (Keytruda, Merck & Co. (MRK)) With Prophage (Agenus Inc.) Autologous Vaccine 1/17/2017 10:02:30 AM
Agenus (AGEN) To Report Third Quarter 2016 Financial Results On October 27, 2016; Conference Call To Follow 10/20/2016 10:13:37 AM
Agenus (AGEN) To Present At The Rodman & Renshaw 18th Annual Global Investment Conference 9/6/2016 1:38:32 PM
Agenus (AGEN) Appoints Jean-Marie Cuillerot, M.D. As Vice President And Global Head Of Clinical Development 7/6/2016 9:29:25 AM
Agenus (AGEN) Announces Commencement Of Phase I/II Clinical Trial Of Anti-GITR Checkpoint Antibody INCAGN1876 In Patients With Solid Tumors 6/22/2016 8:18:46 AM
Agenus (AGEN) Reports Fourth Quarter And Full Year 2015 Financial And Operational Results And Recent Highlights 3/3/2016 11:06:09 AM
Agenus (AGEN) Bags Novel Antibodies to Immuno-oncology Target for $44 Million+ 7/20/2015 5:55:54 AM